MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-31-2025
Integra LifeSciences Holdings Corporation Book Value 2011-2026 | IART
Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.What is included in book value
- Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
- Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
- Assessment of the company's "real" value
Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account. - Comparison with market capitalization
Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market. - Indicator of financial stability
If the book value is high, it indicates the company has significant assets, which reduces risks for investors. - Key component for financial ratios
Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.
Annual Book Value Integra LifeSciences Holdings Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.55 B | 1.59 B | 1.8 B | 1.68 B | 1.51 B | 1.42 B | 1.38 B | 962 M | 840 M | 751 M | 704 M | 670 M | 518 M | 493 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 493 M | 1.13 B |
Quarterly Book Value Integra LifeSciences Holdings Corporation
| 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.04 B | 1.52 B | 1.52 B | 1.53 B | 1.6 B | 1.58 B | 1.68 B | 1.67 B | 1.8 B | 1.72 B | - | 1.62 B | 1.68 B | 1.63 B | 1.57 B | 1.53 B | 1.51 B | 1.51 B | 1.51 B | 1.51 B | 1.42 B | 1.42 B | 1.42 B | 1.42 B | 1.38 B | 1.38 B | 1.38 B | 1.38 B | 962 M | 962 M | 962 M | 962 M | 840 M | 840 M | 840 M | 840 M | 751 M | 751 M | 751 M | 751 M | 704 M | 704 M | 704 M | 704 M | 666 M | 666 M | 666 M | 666 M | 518 M | 518 M | 518 M | 518 M | 493 M | 493 M | 493 M | 493 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.8 B | 493 M | 1.1 B |
Book Value of other stocks in the Medical devices industry
| Issuer | Book Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
ClearPoint Neuro
CLPT
|
28 M | $ 8.99 | -4.16 % | $ 255 M |  USA |
 |
EDAP TMS S.A.
EDAP
|
56.9 M | $ 3.45 | -0.29 % | $ 129 M |  France |
 |
GenMark Diagnostics, Inc.
GNMK
|
196 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
-879 K | - | -26.83 % | $ 2.62 M | USA |
 |
AdaptHealth Corp.
AHCO
|
1.53 B | $ 12.01 | -0.5 % | $ 1.62 B | USA |
 |
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
272 M | - | 24.59 % | $ 44.8 M |  China |
 |
FONAR Corporation
FONR
|
146 M | $ 18.6 | - | $ 122 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
25.5 M | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
1.82 B | $ 36.14 | -1.65 % | $ 5.38 K | USA |
 |
Globus Medical
GMED
|
4.57 B | $ 90.07 | 1.66 % | $ 12.2 B | USA |
 |
Helius Medical Technologies
HSDT
|
2.35 M | $ 1.78 | -6.32 % | $ 1.08 M | USA |
 |
Inspire Medical Systems
INSP
|
781 M | $ 54.06 | -0.15 % | $ 1.59 B | USA |
 |
Apollo Endosurgery
APEN
|
32.6 M | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
4.92 M | $ 1.01 | 1.34 % | $ 17.1 M | USA |
 |
Integer Holdings Corporation
ITGR
|
1.75 B | $ 85.48 | -0.18 % | $ 2.97 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
347 M | $ 15.68 | -1.63 % | $ 368 M | USA |
 |
LENSAR
LNSR
|
-12.2 M | $ 5.83 | -1.1 % | $ 69.7 M | USA |
 |
Medtronic PLC
MDT
|
48.3 B | $ 86.15 | -0.15 % | $ 111 B | USA |
 |
CryoLife, Inc.
CRY
|
58.1 M | - | -4.14 % | $ 702 M | USA |
 |
Myomo
MYO
|
11.4 M | $ 0.66 | -5.68 % | $ 27.6 M | USA |
 |
Avinger
AVGR
|
-6.2 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
3.85 B | $ 166.53 | -3.11 % | $ 12.5 B | USA |
 |
CHF Solutions, Inc.
CHFS
|
6.23 M | - | 1.15 % | $ 34.5 M | USA |
 |
Orthofix Medical
OFIX
|
450 M | $ 11.68 | -0.76 % | $ 463 M |  Curacao |
 |
AxoGen
AXGN
|
129 M | $ 30.86 | -5.45 % | $ 1.42 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
570 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
27.7 M | - | 1.37 % | $ 20.5 M | USA |
 |
Penumbra
PEN
|
1.43 B | $ 329.86 | - | $ 12.8 B | USA |
 |
Soliton, Inc.
SOLY
|
243 M | - | -1.42 % | $ 435 M | USA |
 |
Insulet Corporation
PODD
|
1.52 B | $ 202.45 | -0.52 % | $ 14.2 B | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
2.61 B | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
229 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
30.4 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
52.2 M | - | - | $ 111 M |  Canada |
 |
Sintx Technologies
SINT
|
2.93 M | $ 2.53 | - | $ 7.02 M | USA |
 |
Butterfly Network
BFLY
|
169 M | $ 4.03 | -2.54 % | $ 853 M | USA |
 |
Smith & Nephew plc
SNN
|
5.29 B | $ 31.63 | -3.06 % | $ 23.8 B |  Britain |
 |
Intersect ENT, Inc.
XENT
|
550 M | - | - | $ 955 M | USA |
 |
Stryker Corporation
SYK
|
22.4 B | $ 330.34 | -0.59 % | $ 126 B | USA |
 |
Cytosorbents Corporation
CTSO
|
5.9 M | $ 0.59 | 0.76 % | $ 36.7 M | USA |
 |
Tactile Systems Technology
TCMD
|
219 M | $ 24.31 | -1.06 % | $ 556 M | USA |
 |
TELA Bio
TELA
|
6.31 M | $ 0.67 | 6.38 % | $ 31.5 M | USA |
 |
TransMedics Group
TMDX
|
473 M | $ 106.65 | 1.77 % | $ 3.63 B | USA |
 |
BIOLASE
BIOL
|
1.96 M | - | -13.19 % | $ 166 K | USA |
 |
Tandem Diabetes Care
TNDM
|
155 M | $ 19.31 | 0.74 % | $ 1.31 B | USA |
 |
Delcath Systems
DCTH
|
111 M | $ 9.64 | -0.67 % | $ 345 M | USA |
 |
BioSig Technologies
BSGM
|
133 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
43.7 B | $ 60.97 | -2.6 % | $ 90.3 B | USA |